Edition:
United Kingdom

People: Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

23.35USD
16 Aug 2019
Change (% chg)

$0.72 (+3.18%)
Prev Close
$22.63
Open
$22.79
Day's High
$23.51
Day's Low
$22.59
Volume
187,161
Avg. Vol
250,596
52-wk High
$27.50
52-wk Low
$12.20

Goncalves, Joana 

Dr. Joana Goncalves is Chief Medical Officer of the Company. Prior to joining Cara, Dr. Goncalves worked at Celgene Corporation from April 2014 to October 2018, where she most recently served as Vice President, Medical Affairs for Dermatology and Neurology and was instrumental in planning and executing medical support activities for a number of programs, including OTEZLA® for psoriasis. Previously, Dr. Goncalves held the position of Vice President, Medical Strategy and Scientific Affairs at LEO Pharma Inc., the U.S. subsidiary of LEO Pharma A/S, a global healthcare company specializing in dermatology and critical care, from February 2012 to April 2014. She began her pharmaceutical career at Novartis Pharmaceuticals, working on a range of products across various therapeutic areas from 2001 to 2012. Dr. Goncalves received her M.D. from the University of Cape Town, South Africa.

Basic Compensation

Total Annual Compensation, USD 175,242
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 3,560,950
Fiscal Year Total, USD 3,736,190

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Derek Chalmers

2,789,050

Mani Mohindru

4,046,470

Frederique Menzaghi

1,238,230

Scott Terrillion

--

Joana Goncalves

3,736,190

Martin Vogelbaum

332,261
As Of  31 Dec 2018